Update
Quality key for burgeoning US biosimilars market, says BIO panel
Manufacturing complexity will keep both the number of biosimilar players and pricing discounts low, said an expert panel at BIO last week.
Archives for June 16, 2016
Pfizer breaks ground on new biologics clinical manufacturing facility
Pfizer broke ground on its new Andover, MA-based biologics clinical manufacturing facility this week, which will feature single-use and disposable technologies.
US FDA mulling Emergent Biosolutions' request to make anthrax vaccine at second plant
The US FDA is considering Emergent Biosolutions’ request to make its anthrax vaccine at a second facility in Lansing, Michigan.